Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
123
datasets available to search
ShareScore release 0.9.0
Dataset results
123 results for “Neurological disorders”
A multifaceted hybrid ES-robotic device for gait training in individuals with neurological disorders
<p>Data files acquired during tests and Matlab code necessary for analyzing data and generating the images of the paper </p>
Table Recognition Benchmark on Biomedical Literature on Neurological Disorders
<p>The dataset contains 1650 tables from 1164 PMC OA articles in the context of neurological disorders. The tables are structured in the International Conference on Document Analysis and Recognition (ICDAR) format.</p> <p>The additional csv file contains a labeling into 3 different complexity classes in the format:</p> <p>class document_id table_id</p> <p>with the classes being:</p> <p>0 = simple<br> 1 = complicated<br> 2 = complex</p> <p>You may use the scripts from <a href="https://github.com/TimAdams84/pmc-downloader">this repository</a> to bulk download PDF sources from PMC.</p> <p>A script for evaluating results against the groundtruth data can be found <a href="https://github.com/mnamysl/benchmarking_table_recogn">here</a>.</p>
Neuroimaging Biomarkers of Prognosis in Motor Functional Neurological Disorders
ClinicalTrials.gov study NCT03398070. IPD Sharing: NO. Countries: 1. Publications: 2.
Virtual Reality Rehabilitation for Cognitive, Emotional, and Motor Recovery in Neurological Disorders
ClinicalTrials.gov study NCT06838975. IPD Sharing: YES. Countries: 1. Publications: 3.
Pilot Neurobehavioral Therapy for Functional Neurological Disorder
ClinicalTrials.gov study NCT06873698. IPD Sharing: YES. Countries: 1. Publications: 1.
Neurologic Injuries in Adults With Urea Cycle Disorders
ClinicalTrials.gov study NCT00472732. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disabili
ClinicalTrials.gov study NCT02270736. IPD Sharing: NO. Countries: 6. Publications: 2.
Decreased content of ascorbic acid (vitamin C) in the brain of knockout mouse models of Na+, K+- ATPase-related neurologic disorders
<p><strong><span><span><span><span><span><span><span><span><span><span><span>Raw data, a2Ca3-dKO phenotype and dystonic spell of a3-HT</span></span></span></span></span></span></span></span></span></span></span></strong></p> <p><strong><span><span><span><span><span><span><span><span><span><span><span>We found brain haemorrhage phenotype of Atp1a2 and Atp1a3 doule knockout (α2α3-dKO) foetuses. Here we present two kinds of α2α3-dKO line, α2-Nα3-dKO andα2-Cα3-dKO, both show brain haemorrhage upon birth. They were similar to that of homozygous knockout of the gene encoding ascorbic acid (ASC orNvitamin C) transporter, SVCT2 (SVCT2-KO). We made SVCT2-knockout mouse line by CRIPR/CAS9 method. We present SVCT2-KO, showing brain hemorrage as α2α3-dKO. The α2α3-dKO and SVCT2-KO brain showed significantly decreased level of ASC compared with the wild-type (WT) and single knockout (here, raw data). We found that the ASC content in the basal ganglia and cerebellum was significantly lower in the adult <i>Atp1a3 </i>heterozygous knockout mouse (α3-HT) than in the WT (here, raw data). We did not observe increased oxidative stress in them (here raw data). Interestingly, we observed a significant decrease in the ASC level in the basal ganglia and cerebellum of α3-HTin the peripartum period, during which mice are under physiological stress(here, raw data). Here, we show dystonic spell of α3-HT in peripartum. These observations indicate that the α2 and α3 subunits independently contribute to the ASC level in the foetal brain and that the α3 subunit contributes to ASC transport in the adult basal ganglia and cerebellum. We propose that decreases in ASC levels may affect neural network development and are linked to the pathophysiology of <i>ATP1A2- </i>and <i>ATP1A3</i>-related neurologic disorders.</span></span></span></span></span></span></span></span></span></span></span></strong></p>
Assessment of insight in hospitalized neurological patient: Cognitive profile and mood disorder
<p>Purpose:Many studies have evaluated the characteristics of insight, especially in psychiatric patient pop-ulations. However, this construct has been poorly examined within neurological disorders. We exploredthe relationship between altered insight, mood disorders and neurocognitive functioning in a sample ofpatients admitted to a neurological rehabilitation unit.Method:Each patient, at the time of hospitalization (T0), underwent an evaluation of the overall cogni-tive profile, of the frontal functions, and the compilation of scales aimed at investigating the 4 domainsunder examination of insight and anxiety-depressive symptomatology. After 3 months (T1), at the end ofthe rehabilitative and supportive treatment, the patients underwent the same evaluation performed atT0.Results:Our results showed significant differences between T0 and T1 in the variables examined relatedto insight. In particular, there was a correlation between the global cognitive profile, including executivefunctions, and all insight domains. This confirms how the degree of cognitive deficit, especially of exec-utive type, affects all levels of awareness of the individual.We have also found correlations between mood disorders and insight. In particular, our results showthat depression versus anxiety plays a fundamental role in a person’s awareness.Conclusions:The study of insight is fundamental not only for the relapses it could have on the patient, butalso on those to health care professionals. In fact, having an adequate insight could lead to a greater moti-vation of the patient to be more complimentary to pharmacological and rehabilitative therapies, alsofavoring social reintegration.</p>
Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences)
ClinicalTrials.gov study NCT04362930. IPD Sharing: NO. Countries: 1. Publications: 1.
Embodied Virtual Reality Therapy for Functional Neurological Symptom/ Conversion Disorder
ClinicalTrials.gov study NCT02764476. IPD Sharing: NO. Countries: 1. Publications: 1.
Multidisciplinary Lifestyle Interventions for Neurological Disorders During the Silent Phase
ClinicalTrials.gov study NCT05984056. IPD Sharing: NO. Countries: 1. Publications: 11.
Dance/Movement Therapy for Functional Neurological Disorder
ClinicalTrials.gov study NCT07378488. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
Efficacy and Safety of TMS and Deep TMS Treatment for Psychiatric and Neurological Disorders
ClinicalTrials.gov study NCT02917499. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The DANCEREX Proof-of-Concept Study for Chronic Neurological Disorders
ClinicalTrials.gov study NCT06112639. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Accelerated TMS for Seizure-Type Functional Neurologic Disorders
ClinicalTrials.gov study NCT07059325. IPD Sharing: NO. Countries: 1. Publications: 26.
Rebound Exercise in Neurological Disorders
ClinicalTrials.gov study NCT05526508. IPD Sharing: YES. Countries: 1. Publications: 7.
Neurologic Signatures of Chronic Pain Disorders
ClinicalTrials.gov study NCT02747940. IPD Sharing: NO. Countries: 1. Publications: 5.
National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial
ClinicalTrials.gov study NCT00063193. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The French Cohort and Biobank of Devic's Neuromyelitis Optica and Related Neurological Disorders (NMOSD) (NOMADMUS)
ClinicalTrials.gov study NCT02850705. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.